ESR1 and breast cancer: Initial studies of glyceollins’ biological effects indicated that they were estrogen receptor antagonists [19], exhibited anti-proliferative effects in estrogen-dependent breast cancer cells [20] and inhibited cell proliferation in mouse xenograft breast cancer models [21].